2003
DOI: 10.1120/jacmp.v4i2.2528
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of an in vivo diode dosimetry system for clinical use

Abstract: An in vivo dosimetry system that uses p‐type semiconductor diodes with buildup caps was characterized for clinical use on accelerators ranging in energy from 4 to 18 MV. The dose per pulse dependence was investigated. This was done by altering the source‐surface distance, field size, and wedge for photons. The off‐axis correction and effect of changing repetition rate were also investigated. A model was developed to fit the measured two‐dimensional diode correction factors.PACS number(s): 87.66.–a, 87.52.–g

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 16 publications
1
8
0
Order By: Relevance
“…who reported that since it is difficult to put the diode dosimeter at the central axis accurately, a larger tolerance should be considered for wedged fields when performing in vivo dosimetry. [ 11 ]…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…who reported that since it is difficult to put the diode dosimeter at the central axis accurately, a larger tolerance should be considered for wedged fields when performing in vivo dosimetry. [ 11 ]…”
Section: Discussionmentioning
confidence: 99%
“…These consist of the measurement of calibration and correction factors (CFs), checking the system, methodology and the use of the factors in practice; and clinical pilot studies to establish the existing accuracy and precision of given treatment situation. [ 11 13 ] The ideal diode for in vivo dosimetry should show minimal dependence on field size, source–skin distance (SSD) and interposition of modifying devices such as wedges. [ 1 4 14 ] CFs need to be modified with accumulating dose.…”
Section: Introductionmentioning
confidence: 99%
“…The difference in electronic contamination and scatter radiation received by a diode on the surface and an ionization chamber at dmax causes a variation in CFs with field size (31) . Both ascending and descending variation of CFs with field size are reported for different diodes at various energies 3 , 28 , 32 . In this study, the field size CF for both diodes had ascending variation for cobalt‐60 and descending variation at 9 MV.…”
Section: Discussionmentioning
confidence: 53%
“…Several investigators have characterized commercial diodes experimentally and measured their CFs at various energies, 3 , 17 , 25 , 27 but there is little published data on such factors for low‐perturbation diodes. Also, to the best of our knowledge, there is no published data on diode characterization for 9 MV photons.…”
Section: Introductionmentioning
confidence: 99%
“…In vivo measurements are performed at several locations, with these measurements requiring high spatial resolution, high sensitivity, and low dose influence, over a broad range of doses. Silicon diodes, Gafchromic films, metal-oxide-semiconductor field-effect transistors (MOSFETs), and thermoluminescence detectors (TLDs) are all currently used as in vivo dosimetric tools [8][9][10][11][12][13][14]. These sensors each have their own inherent advantages and disadvantages.…”
Section: Introductionmentioning
confidence: 99%